Poly(p-dioxanone) has high degree of crystallinity which limited it to copolymerize with other monomers to be used as controlled drug release materials.
但聚二氧六环酮的结晶度较高，不适合直接用做药物控释材料，需要与其他单体进行共聚以改善其亲水性和结晶性等性质。
Poly(p-dioxanone) has high degree of crystallinity which limited it to copolymerize with other monomers to be used as controlled drug release materials.
但聚二氧六环酮的结晶度较高，不适合直接用做药物控释材料，需要与其他单体进行共聚以改善其亲水性和结晶性等性质。
应用推荐